Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bingo. You are on to the situation.
After reading the board when I got up this morning I was surprised to see the banter going back and forth.
This recent situation with JT is not as bad as some are making it out to be.
Anyway, I am all over the issue regarding the patents and will let everyone know what is up once I know - however I have a busy day today.
Will definitely report back when I hear something.
On a slight aside, in case anyone was wondering, I found out that few warrants have been exercised since April, As we continue to trade around the 52-week high and higher, I expect to see some warrants from the recent financings to hit the market as they become in the money (specifically the TMD.WT.D for $2.75 with an April 23, 2017 expiration).
Have a great day.
Long and strong (and not fazed by the JT departure)
What a joke. No I have never heard of the them, however, for fun I will do my research (which it appears might be quick). I will not waste too much time on this either. From my quick skim it appears the author is quite bias and ignorant of the end users in the marketplace.
The market is smarter and the market is mostly right when it comes to things like this. As you can see, this article was ignored today. The analyst has probably never been down to see the product either.
This is what makes a market.
I hope they are short and I hope they have clients who are short if they are a real brokerage firm because they will get burned here.
Long and strong.
Hi everyone,
What a nice day of trading to end the month and the quarter. We should all be happy as a general rule.
Beverly is gone (yeahhh). Sherry is in (yahoo!!!!!!!!!!!!!!!)
We traded very well today until the last 20 minutes or so of trading when Dundee sparked the sell-off with what appears to be a market order for 50,000 shares. Right after that a whole lot of other selling followed.
I am certain what you saw today was all sorts of portfolio managers locking in their profits for both the month end but most importantly the quarter end. Their attitude is who cares about an extra $0.10 when their bonuses are bases on net performance. This end of day giving back $0.10 to $0.14 is no big deal for us long-term holders – in fact it’s perfectly fine as now those shares are out of the way and beginning tomorrow (or Wednesday for us Canadians – due to Canada Day tomorrow) it appears to be clear and smooth sailing.
Happy Canada Day to my fellow Canadians.
Great things still on the horizon.
(FYI, Theralase had a good day today as well)
Long and strong.
My take on Joe Talarico's departure is that it is insignificant in the grand scheme of things, and in fact may even be quite prudent.
Joe "quit", but I think that was really just indicative of the direction Titan is headed. I think we can feel good about today's news because it gives us further reassurance that management is not sitting by idly. Joe was not an integral part of the team.
At the AGM, Joe introduced Corey Libby from Ximedica and seemed to be acting as the liason or the go-to-guy between Titan and Ximedica. His background is in sales, with Intuitive and U.S. Surgical, and that's where his real value was.
Today's departure makes me consider what Lurker05 and Arby2000 have also already wondered... "Who is going to replace him?"
Either, Titan management will hire a new VP Business Development, someone with a similar if not more impressive background than Joe. Or they will look outside of the company and go with a 3rd party.
Which then leads to another question, has management shifted strategy with sales and marketing?
The departure of BB and JT, and the hiring of Sherry makes me think, yes. Management seems intent on getting the SPORT to market as quickly as possible, and with the most qualified people.
I always felt that Joe was qualified to lead the sales team, so today's announcement adds credence to the strategy shift and corresponds with other recent moves. Switching things up and going with a 3rd party who specializes in medical device sales and already has significant/established connections to hospitals and group purchasing organizations would be most efficient for Titan.
You are correct however my post was made based on past history with med companies like Titan and not Pharma companies. In the past the average premium paid was around 100%.
I hope you are right and the consolidation continues so we get that 200% - 400% premium.
My mistake in making it sound like the 100% premium was carved in stone.
Long and strong
Noemotionseller,
I agree with 95% of what you say with the exception of your numbers.
Other takeouts in the space have been at approximately a 100% premium and not a 300% to 400% premium. If ISRG were to make a run for Titan today they might offer $5.00 per share (which I think we can all agree is way too undervalued). This is based on its current price range of $2.50 give or take a bit.
Now you see why many including myself have been critical of management to put out some type of news (without compromising the company's confidential information). The higher the price, even today, protects us all should a company come along and make a run for Titan.
Hopefully no one makes any bid for Titan in the near future because once they do their design freeze and FDA Application, that milestone should increase the valuation. As Titan continues to hit milestones, the PPS should get a complimentary bump, and risk will decrease. And so on and so forth. That being said, even post-FDA approval, premiums are only in the 100% range only - not that someone might not offer a higher premium.
If another company really wants Titan and really wants to make a statement to chase away competitive bids for Titan, then you might actually see a higher bid than the standard 100% average premium. Just my thought. Hypothetically, GE or JNJ could come in, have a look around, be very impressed with what they see and how far along Titan is, and make a substantial offer. The MedTech space has been heating up lately.
What Titan has on its side, as you suggest, are many surgeons who cannot stand ISRG as well as many other competitors who would love to get in this space. This alone might be enough to create a decent bidding war and drive the price up well past that 100% average premium takeout range.
Best scenario as you suggest is that Titan goes at it alone. However, I truly believe a large player will step in sometime after they get their FDA approval with some type of offer.
Long and strong
I agree. People (money managers and or other professional money managers like hedge fund managers) are shorting the stock after a big run and they are shorting hard – especially if they have the warrants to cover the short as a worst scenario.
If they take the momentum out of the stock and the share price drops further, they buy in on the open market to cover the short – if the price holds or rises, they simply exercise their warrants to cover the short.
Long and strong
Today was perfectly fine.
Lots of selling came in mid-day and the volume picked up.
I was at a meeting with my friend and we were watching it. Not even a flinch when it was down about $0.30.
We discussed it and agreed that it is totally healthy for the share price to consolidate a bit especially after the recent large run up Titan has had. We even bet how much it would recover from the low, and my friend was right saying it would probably regain half of the losses, which it did, closing down only $0.14 versus $0.30 in Canada.
Stocks don’t go straight up forever without people taking profits and consolidation. Although I too would have loved to see this hit the old highs, I am not bothered at all. Frankly in hindsight I am happy this happened sooner than later. All stocks need to consolidate and this one is doing it now. My bigger fear would have been that this would be happening with less volume – but that is not the case.
In Canada, Titan traded 1,485,300 shares on 7 exchanges today and on the U.S., another 1,458,300 shares. I had to check those numbers a few times because they were so close.
Today's mid-day sell off was good and got rid of investors who were scared of the pull back.
Let’s not forget that around noon today the market was up about 30 – 40 points and then suddenly dropped and closed down 119 points.
Remember, the big buyers recently were the U.S. funds and when the market turned, so did Titan.
All is good and healthy.
Long and strong
Barefootin, I am not sure if people are serious or not but there has been some talk of Vegas. I will surely be there if everyone else goes.
I am a Toronto guy.
Regarding my position, I can tell you that it’s not my only position but I can tell you that it’s my largest position and way over-weighted.
See you in Vegas.
Long and strong
I have never received a Titan newsletter either.
Not sure they are going to have one. My belief is that they will simply have press releases and update their website for news.
I think what everyone may have received was a standard consent provided by their lawyers to send out to everyone on their e-mail list today. What the lawyers probably suggested is to send enough of a request to include press releases and newsletters….so Titan does not get in trouble later on.
They don’t have the time to write news letters in my opinion.
Long and strong
Hahahaha.
I am with you all the way!!!
Long and strong
Totally agree with you.
In my opinion she will normally see U.S. companies that already have a following and a decent market cap.
Titan is a small Canadian company that is extremely undervalued and so as it begins to increase to its real value, she gets the benefit of showing what she can do (and how she assisted it through this process).
She is great however.
Long and strong
CUIN2,
In this case, it has nothing to do with Sherry.
Coincidence in this case, not. It’s the law up here now.
I have been receiving 10 of these a day for the last month from various companies. It relates to the new Anti-Spam laws.
You have to opt-in to receive information or news releases.
Long and strong
www.canadianinsider.com
CUIN2, you are correct,
In Canada today the volume on all the exchanges was 1,011,700.
Titan traded on the TSX.V, Alpha, Chi-X, CX2, Pure, Omega, TMX Select and TriAct or a total of 8 difference exchanges.
FYI, on one exchange the volume was as low as 500 shares.
Long and strong
Agree.
Long and strong
Not hard enough. You are 100% wrong.
BB was in over her head and did not deliver anything material to Titan.
I have the inside scoop in Toronto so I know the actual performance.
Bayfront discovered the company on their own (thankfully they did) and they brought in Dundee as they needed an IIROC firm to assist in the raise who could sign a prospectus. FYI, Dundee did a great job as well. This was not a BB thing.
I am not trying to be vicious, I am simply saying it as it is. I was equally critical of the company and its lack of news releases too. Never once did I comment on their product or the way they run their business – the only comments were directed at their weaknesses which ultimately got resolved – for all our benefits.
You are correct that Sherry is much better connected……
Long and strong
Flenderson,
I think longer term we keep on pushing here to new highs. I think we might even do it this week (and hopefully we will do it this week).
Don’t get spooked but on a red day in the markets even our beloved Titan might fall back a few pennies, especially after the recent run up.
The buying you are seeing is strong US buying and momentum players jumping on board. This can be witnessed by the pick up in U.S. volume versus the Canadian volume.
I am not a technical guy, but I think you will see the price run through $3 sooner than you all think. All you need is one or two institutions to begin to pick up shares to the point of owning 9.5% of the float where they don’t have to report their holdings and the shares get cleaned up. From what I can tell, this is starting to actually happen.
Imagine what happens is this goes to $3 and a whole world of new institutional investors start to pile in!!!!!!!!!
Long and strong
Poor BB.
She was in over her head. She must really feel useless at this point because you can see what is going on here. SB in and BB out and the rating on each can be seen by the performance.
Anyway, smaller institutions are already buying in which is what is going on right now. Once we are solid above $3.00 Titan will make that leap. Once that happens, a whole new set of institutions will be allowed to step in and it's game over for the low price. I could not agree with you any more when you say a $3 - $4 bump. That will take this to $7 and hopefully more!!!
Long and strong
You are so right.
You have the price and time frame right on the money.
As soon as the design freeze is done we are off to the races.
Long and strong
Barefootin,
First of all I love the name as the name Barefootin to me refers to water-skiing barefoot – which once upon a time I used to do.
Secondly, as I stated before you can count both me and my friend in.
He loves to stay at Aria but did suggest we try Wynn or Encore
Bottom line, there are two of us ready to go.
Long and strong
WhoDey1,
Go ahead and sell as you are being prudent in taking profits if you are uncomfortable with the stock. No one ever got hurt taking a profit.
If you are however selling due to concerns about a reverse split, then you are selling for the wrong reason. There is no reverse split coming any time soon – especially given the price action of the stock.
Titan management has their head down developing a product and if now also finally doing some marketing of their company….
The only way they can do a R/S is by calling a Special Meeting of the shareholders and having the shareholders vote, alternatively they will have to wait until next AGM (next year). By that time we will know where they stand with their development, their product design and their FDA application.
There is NO reverse split in the cards.
Long and strong on this end.
I echo you comments.
There has been lots of great information on this board shared by everyone.
Doctors, other medical professionals, medical reps and capital markets professionals.....
Thanks to you all and keep up the great work.
Long and strong.
Great everyone.
As someone mentioned earlier this stock will change many peoples lives as it has done for my friend who has been in since the very beginning.
Regarding the roll back issue, I don't think it's in the cards. I believe this up-listing will be done by way of organic growth. Titan would rather go out and continue to tell their story and focus on developing their product - in other words, simply stay focused.
Would they do an up-listing when they reach the right price.....(meet all requirements) I would assume so. Don't think that Sherry has not mentioned this to them already.
I don't see Titan holding a special meeting to get shareholder approval to do this. If they were to, it would not happen until next years AGM by which point we will have lots of clarity where they stand regarding their "technology freeze" and FDA applications. If all this goes as planned and on track as they are currently, this company's share price (notice the grammar I used here - I did not say "companies" - just having some fun with the grammar nitpicking lately) will be much higher than it is currently and they will be able to up-list on their own.
Again, I have not spoken to the company about this but I know and understand the psychology of the players involved.
Have a great weekend.
Long and strong
I'll get that quote.
Further to my earlier post, I forgot to mention that the U.S. volume has again picked up and yesterday was substantially higher than the Canadian volume which itself was extremely strong. This too is a very bullish signal.
Titan will want this to get to U.S. $3.00 or higher so they can attract more funds into the story - once they uplist to Nasdaq. Not to worry, no roll-back.
Anyway, I feel stronger about the recent activity in Titan as well and it looks like it will continue.
Long and strong
Calling all involved in the industry to respond. I’m looking to write a third article and need your help. Anyone in the industry (physicians and specialists (surgeons, anesthesiologists, etc.), hospital administrators or management, sales reps, or anyone else who thinks that their input would add to the article is encouraged to private message me a short piece of writing...
After reading Lurker05’s post from the other day, and then VeNoM12’s, Robs911’s, and CUIN2’s responses, I had an idea for a new article. Let’s highlight the differences between Titan’s SPORT and TransEnterix’s SurgiBot from the people who know the machines best, those with an intimate knowledge of what is needed in one – the end or near-end users.
So, I would like to pose two questions for those qualified to answer:
What makes the SPORT the most ideal platform between it and TRXC’s SurgiBot?
Which do you believe has the most potential and why?
Don’t work about your responses being too bias, that’s expected. This is the TITXF board, the article will be on TITXF, and we’re all invested in TITXF, so inherently, there will be bias.
If you could inbox (private message) me a brief synopsis of your personal details (what you do, how many cases/procedures a year, your involvement in the industry, etc. – that type of stuff), and also provide commentary to the above questions, that would be much appreciated – bullet points or paragraphs, whatever works for you. All contributors to the discussion will remain anonymous and will be labeled generically in the article (i.e. Surgeon 1, Sales Rep 2, etc.)
I think it’s fascinating to hear the differences in functionality between the two units from the (near) end user, and what their thoughts are on the companies and I think that others will really appreciate it as well.
Looking forward to the PM’s. And remember this is totally voluntary and anonymous, but the more responses the more detailed and thorough the sample will be.
If anyone has anything to add, or any suggestions or comments, don't be shy.
Long and strong.
Hah! Had a chuckle at that one. Beneath all of his bashing even LTG can appreciate what Titan has.
But in all seriousness, it's been a great week for the company. Not just one, but TWO press releases this week! Out with the old in with the new - bye bye BB, good riddance, hello Sherry.
Others have commented one what it will take to propel Titan to the next level. Hitting milestones will certainly do so, and news like we've got this week is great - as long as it happens more frequently we will continue to get bumps up; management needs to continue to demonstrate that they can perform.
The next big event that needs to happen to take Titan to the next level is an uplisting. Many institutions won't touch Titan until then. Period. This should happen sooner than later.
El Guapo - What we’re seeing, the large lots and the volume is just that, institutional buying.
While our iHub board and its contributors are perhaps the most sophisticated group I’ve ever had the privilege to participate with, and, as a whole, all of our efforts definitely do make an impact, a significant portion of the volume this week can be directly attributed to U.S. institutional buying, spurred largely by Sherry Bertner. She came at a price but I must say, with the news and the buying this week, it's been an excellent start. I haven’t had the chance to meet her yet, but I’ve heard phenomenal things about her. She is supposed to be extremely well connected.
Theralase to work with U Toledo on PDC research
Ticker Symbol: C:TLT
Theralase to work with U Toledo on PDC research
Theralase Technologies Inc (C:TLT)
Shares Issued 77,493,809
Last Close 6/17/2014 $0.33
Wednesday June 18 2014 - News Release
Mr. Roger Dumoulin-White reports
THERALASE PARTNERS WITH UNIVERSITY OF TOLEDO IN CANCER RESEARCH
Theralase Technologies Inc. has executed an agreement with the University of Toledo to conduct preclinical research into the safety and effectiveness of Theralase's photodynamic compounds in the destruction of bladder cancer in a rat model. The study is entitled, "The use of novel Photo Dynamic Therapy (PDT) in a rat bladder tumor model." The first phase of this preclinical study will be to optimize the effectiveness of various Theralase PDCs in the destruction of rat bladder tumor cells (AY-27) using various PDC concentrations and laser light doses.The second phase will be to complete two in vivo rat tumor model studies. The first set of experiments will examine PDC uptake and distribution in rat bladder tumors. The second set of experiments will focus on destroying rat bladder cancer safely and effectively through the instillation of PDCs into rat bladders exhibiting cancerous tumours and then light activating them. The outcome of these experiments will provide independent confirmation and optimization of the lead PDC selected for bladder cancer destruction and prove the safety and efficacy of the Theralase lead PDC in the destruction of bladder cancer in a live animal model.Dr. Arkady Mandel, Chief Scientific Officer at Theralase Inc. stated, "I am interested in reviewing the results of an independent confirmation and optimization of the safety and efficacy of the Theralase PDC in destroying bladder cancer in an orthotopic (occurring at the normal place) rat model. The University of Toledo is a great choice for this research, as their group is well known for expertise in the urological applications of PDT. The results of this preclinical research will allow the Company to progress to Good Manufacturing Practice (GMP) manufacture of the lead PDC. We are delighted to have the experience and knowledge of the University of Toledo on board to execute this pivotal preclinical research, as they will be instrumental in helping us prove the destruction of rat bladder cancer with PDCs in 2014, preparing us for clinical application in 2015."Roger Dumoulin-White, President and CEO of Theralase stated that, "Theralase is delighted that we have executed a research agreement with the University of Toledo. Completion of this work is pivotal for Theralase to independently validate and optimize our research findings in the PDT destruction of bladder cancer. Results of the University of Toledo's work will determine the uptake and distribution of the PDCs into bladder cancer tumors versus healthy bladder and the amount of PDCs required to safely and effectively destroy bladder cancer in a live animal model. This data will be instrumental in helping to determine the proper amount of PDC required for human application. I look forward to reporting on the results of this exciting research later this year."
We seek Safe Harbor.
© 2014 Canjex Publishing Ltd.
This is great news that they are working with Bertner Advisors LLC.
She knows everyone in the medical space unlike Brooks.
Finally a real positive change. She will open doors they would normally never get to as well.
Price is a little steep so I hope to see some real positive results over the next few months but even so, this is great news.
Long and strong
She is amazing! Bertner knows everyone.
... BB also out.
Titan Medical hires Bertner as IR adviser
2014-06-17 08:51 ET - News Release
Mr. John Hargrove reports
TITAN MEDICAL INC. RETAINS NEW YORK-BASED BERTNER ADVISORS, LLC FOR INVESTOR RELATIONS SERVICES
Titan Medical Inc. has retained Bertner Advisors LLC as its investor relations adviser. Services to be provided in the United States to Titan by Bertner Advisors include counsel on investor relations strategy.
Headquartered in New York City, Bertner Advisors is a financial communications consulting firm providing strategic investor relations services to health care companies. The Titan Client Management Team providing these services includes Monique Kosse, Managing Director, and Lena Adams, Associate Director. Bertner Advisors, LLC is privately held and solely owned by Sherry L. Bertner, who founded the firm in 2013.
Sherry Bertner, Chief Executive Officer of Bertner Advisors, commented, "Our team is thrilled to partner with Titan Medical. We look forward to working with management to design and execute an investor relations strategy that includes introducing the Titan story to Wall Street."
John Hargrove, Chief Executive Officer of Titan, said, "We believe Bertner Advisors will enable us to extend our investor reach and to build awareness on Wall Street. The Firm is a perfect fit for Titan as we continue to move closer to commercialization of the SPORT? Surgical System and will enhance a great team, a great technology and a tremendous opportunity."
The agreement for the engagement of Bertner Advisors will commence on July 7, 2014 for a term of 36 months. Bertner Advisors will be paid fees of US$20,000 per month for its services, with an annual increase of 5% on such monthly fee. An additional fee of six times the monthly fee shall be paid to Bertner Advisors in the event that a merger, acquisition, consolidation, or other transaction occurs, pursuant to which all or substantially all of the stock, assets, or other interests in Titan are sold or otherwise conveyed, and such transaction results in a new person or entity obtaining a fifty percent (50%) or greater ownership interest in or control over Titan.
The Company's current investor relations and financial communications services contract with Brooks Communications will end effective on June 30, 2014. Titan would like to take the opportunity to thank Beverly Brooks for her services to the Company.
We seek Safe Harbor.
You are welcome.
As stated before, let the board keep on providing the information on the industry and I will try to do my role.
To answer your question re: the design freeze, I'm optimistic that they will complete it by the end of the year. However, I wouldn't be shocked if it took till say, February. It's contingent on management achieving milestones which they've been successful at so far. Right now, the team at Ximedica is working diligently trying to optimize and refine the SPORT. They seemed quite competent to me and I believe that they're on track.
Long and strong
What hotel are we all staying at?
I love the Aria however I have still never stayed at Wynn or Encore.
See you all in Vegas.
Long and strong – Viva Las Vegas
I think the shorts are starting to get afraid and cover.
Today my friend received a call to borrow his shares for some shorters who might be getting buy in calls.
This will be positive for the share price.
Long and strong
Thanks very much.
I am not the new go to IR person and did not replace BB – however useless her services are.
My article is simply a way of trying to peg a value on the company and I hope I justified the model to you and everyone else.
Long and strong
El Guapo,
It’s a GREAT milestone as it also re-confirms they are on target with respect to their timelines!!!!!!
I completely agree with you.
Long and strong
I don’t think most of the people on this board are being impatient.
Rather, Titan management has a responsibility to both run and company and also to manage shareholders and their (varying) expectations.
No one on this board wants them to release anything that will compromise the company and give competitive and confidential information away that would harm the company….
There is however lots of other information the company could release like they did about a month or so back as well as today that does not give away any information to compromise the company.
I for one appreciate the information put out by the company and hope they will continue to release such information. It attracts new investors, scares competitors and or draws them closer to do a JV – frankly it's positive.
You and I KC, we're both long term thinkers – but as mentioned earlier, I expect the company to release information along the way which keeps us informed and also helps the share price so when the time comes for a real move in the share price, we are doing it from a higher level.
Long and strong
Amen to that.